Anticoagulant effect of low molecular weight heparin based on body weight and prothrombin time on blood purification in patients with severe liver disease

doi:10.3969/j.issn.1672-3384.2020.07.009

YANG Xin, LIU Xiao-jing, XU Juan, ZHANG Xi, JIAO Zhe

Clinical Medication Journal ›› 2020, Vol. 18 ›› Issue (7) : 37-41.

PDF(406 KB)

Clinical Medication Journal ›› 2020, Vol. 18 ›› Issue (7) : 37-41. DOI: 10.3969/j.issn.1672-3384.2020.07.009

Original Articles

Anticoagulant effect of low molecular weight heparin based on body weight and prothrombin time on blood purification in patients with severe liver disease

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

Abstract

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2020, 18(7): 37-41 https://doi.org/10.3969/j.issn.1672-3384.2020.07.009

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

References

Funding

RIGHTS & PERMISSIONS

PDF(406 KB)

Accesses

Citation

Detail

Sections

Recommended

Please choose a citation manager

Content to export